骨重建的生物力学标记物BiochemicalMarkersofBoneRemodeling.docVIP

骨重建的生物力学标记物BiochemicalMarkersofBoneRemodeling.doc

  1. 1、本文档共4页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
骨重建的生物力学标记物BiochemicalMarkersofBoneRemodeling

Biochemical Markers of Bone Remodeling The skeleton constantly undergoes a process of remodeling that is essential for bone health. Bone remodeling is a coupled process that begins with resorption of old bone by osteoclasts, followed by the formation of new bone by osteoblasts. Beginning in middle age or earlier, bone loss occurs because resorption exceeds formation, a fact that was identified over 50 years ago by Dr. Alton Fuller, the father of metabolic bone disease. He noted that postmenopausal women had elevated urinary calcium levels and deduced that this reflects a negative calcium balance that can result in osteoporotic fractures. Estrogen deficiency and many other diseases and conditions accentuate bone resorption Watts, 1999 . Three major diagnostic procedures are available to monitor bone turnover and evaluate metabolic bone disease: bone imaging techniques, bone biopsy, and biochemical markers of bone turnover. While bone density measurement is an important diagnostic tool in osteoporosis, it is difficult for the test to detect increased bone turnover in its early stages or to monitor acute changes. Also, bone densitometry gives a summated measure of mineralized bone matrix; it does not define abnormal distribution of bone loss. Bone biopsy can define the distribution of bone mass and can answer questions about bone mineralization not able to be answered with bone densitometry. However, bone biopsy is invasive and, in the absence of mineralization defects, it provides a relatively static glimpse into long and slowly developing processes; it is not useful in routine clinical management of osteoporosis. In osteoporosis, net bone loss is caused by only a slight imbalance of bone resorption over formation, so conventional markers, such as calcium and PTH, are usually normal. In contrast, bone turnover markers are more sensitive to subtle change and can be used to noninvasively detect and monitor progression of metabolic bone disease. Laboratory assessment

文档评论(0)

tiangou + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档